Answers are grounded in this paper and cite their sources.
Background: Avidin (AV) represents the third most important protein of major commercial interest derived from egg white, alongside ovotransferrin and lysozyme. It constitutes only 0.05% of the total protein content. Despite the widespread natural availability of AV, its purification remains a significant challenge due to its low abundance within a highly concentrated and complex protein matrix. Methods: Developing efficient downstream processing for AV has the potential to significantly enhance profitability within the egg protein industry. This work presents a novel integrated process for AV recovery. It comprises ovomucin removal, AV preconcentration, and final purification using pseudo-affinity chromatography. The latter utilizes a novel resin with 4′-hydroxyazobenzene-2-carboxylic acid (HABA) as the ligand. The HABA–agarose matrix was characterized by an adsorption isotherm and breakthrough curves, indicating an AV adsorption performance higher than that of other pseudo-affinity matrices. Results and Conclusions: The HABA pseudo-affinity chromatographic process was a crucial step to purify AV more than 300-fold with high yield (86%). Despite the low AV recovery, the proposed integrated process aligns with the biorefinery concept, which maximizes the economic value of raw materials by utilizing all components.
No takes yet. Share an insight, caveat, or question.
Rios et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: